The FDA-approved thiazolidinedione class of drugs (Figure 7) for treating diabetes attenuate the AGE-RAGE interactions through an indirect mechanism: they inhibit the formation of RAGE and induce the expression of s-RAGE through the activation of the peroxisome proliferator-activated receptor gamma (PPAR-γ) [58,59]. Here, AGER is linked to diabetes mellitus.